Home Blog Page 3368

Disney’s 20th Anniversary: HKDL Ambassadors Prepare to Pass the Torch

Seeking the Next Ambassador to Continue the Mission of Spreading Magic and Helping Others

HONG KONG SAR – Media OutReach Newswire – 25 April 2025 – Hong Kong Disneyland Resort (HKDL) has been a cornerstone of joy and magical memories for 20 years, delighting guests and fans while also dedicating itself to community service. The 2024-2025 Disney Ambassadors Gisele Abejero and Beyan Tse represent the resort, working alongside Disney VoluntEARS to bring Disney magic to those in need, including young patients, underprivileged families, people with disabilities, and minority groups.

Cover Photo (Gisele and Beyan)
Cover Photo (Gisele and Beyan)

As HKDL celebrates its 20th anniversary, the pair and all cast members invite everyone to join the grand celebration starting from June 28. With their term coming to an end, they are also on the search for the next ambassador(s) to continue spreading Disney’s legacy of joy and magic.
Stepping Out of Comfort Zones: Unlocking New Skills
Gisele, who hails from the Philippines, and Beyan, a native Hongkonger, come from vastly different backgrounds and life experiences. They have shown incredible courage in stepping out of their comfort zones to pursue their dreams, shaping who they are today.
Gisele, who has been working at HKDL for 17 years, is the first Disney Ambassador of Filipino descent at HKDL. She began her career at the Entertainment team and showcasing her extensive stage experience in different shows including “The Golden Mickeys”, “Mickey and the Wondrous Book” and “Festival of the Lion King.” She shared, “As a dancer, I rarely speak or interact directly with guests on stage. As Disney Ambassador, I have to frequently engage with different people and even host events. I keep learning and growing. I unlock new skills along the way and discovering a different side of myself.”
Beyan has been a lifelong Disney fan. Previously working behind the scenes in Sourcing, she made the bold decision to step into the spotlight. She recalled, “becoming a Disney Ambassador is the bravest decision I have ever made in my life. Over the past year, I have visited various operational teams, including food & beverage, housekeeping and horticulture, taking on different roles and participating in daily tasks. These experiences have boosted my confidence, and very proud of every professional and passionate cast member.”
Reaching Every Corner of the Community: Spreading Disney Magic
Gisele and Beyan have actively participated in various community service initiatives, supporting Disney VoluntEARS and bringing Disney magic to life through their work. Last year, HKDL collaborated with Heep Hong Society to launch a first-ever and largest pilot program offering real-life social adaptation training for children with special educational needs (SEN). Gisele and Beyan, along with Disney VoluntEARS, engaging in activities such as ordering food at park restaurants and queuing for shopping. This program provides unique training experience for children with SEN, giving them more opportunities to practice and integrate into the community.
As the mother of three children including a daughter with SEN, Gisele shared her experience: “As a mother of an SEN child, I deeply understand the challenges of taking children out. As Disney Ambassador, I aim to raise awareness and support for SEN children through my participation in events, helping them feel more love and care.” Gisele affirmed her commitment to continue participating in related activities even after her term ends. She believes that being a Disney Ambassador is not just a two-year role but a lifelong commitment to supporting both the resort and the community.
Gisele and Beyan also joined Mickey and Minnie Mouse in visiting children at the Hong Kong Children’s Hospital and took part in HKDL’s Christmas toy donation campaign. Additionally, they worked closely with the Make-A-Wish®, creating unique park experiences for wish children. Since 2008, HKDL has made over 340 wishes come true.
Beyan recalled several heartwarming stories from the wish kids: “One little girl, dressed as a princess, met her favorite Elsa, and it felt like the whole world stood still. Her pure smile was truly touching.” Another memorable moment involved a boy with illness who was using a wheelchair. Despite his frail condition, when he saw the beloved Mickey Mouse, he mustered all his strength to lift his hand and give him a high-five, leaving even his parents in awe. “Seeing him completely immersed in the happiness of that moment made me realize the true mission of Disney Ambassadors — to create hope with Disney magic,” Beyan said.
Bridging Connections Through Media: Sharing Disney Fun Facts
Beyond their community service, Gisele and Beyan have been actively sharing park updates and behind-the-scenes moments from their daily live through the official HKDL Ambassador social media accounts. They’ve also produced a series of engaging interactive videos, such as “Ambassador’s Vlog” and “Trivia Game On”. These fun-filled videos highlight little-known Disney trivia, bridging the gap between cast members and guests. The duo happily shared, “Many fans who spot us filming in the park often seize the opportunity to get on camera!”
Speaking of trivia, here’s a question for you: What gift did the Beast give Belle to express his love? You can find the answer on the HKDL Ambassador Instagram and Facebook pages!

Embark on an Extraordinary Journey – Become the Next Disney Ambassador
Gisele and Beyan’s stories showcase how Disney magic transforms live and inspires everyone to believe in the power of dreams and happiness. Their journey as Disney Ambassadors is profoundly meaningful and enriched with unique experiences. Becoming a Disney Ambassador is a once-in-a-lifetime journey filled with invaluable experiences, such as participating in professional training and exchanges with global Disney Ambassadors and having the opportunity to attend the D23 Expo in California, interacting with and inspiring countless dreamers.
This year, as HKDL celebrates its 20th anniversary, Gisele and Beyan have the honor of commemorating this significant milestone with everyone. With their two-year term coming to an end this year, they are actively searching for the next ambassador(s). “Passion, positive attitude, and a willingness to embrace new challenges are keys to success!” they shared. The 2026-2027 HKDL Ambassador Program is now open for applications until May 19. All eligible full-time cast members and imagineers with at least two years of work experience at HKDL and fluency in Cantonese or English are invited to apply and embark on this one-of-a-kind journey!

Hashtag: #HongKongDisneylandResort

The issuer is solely responsible for the content of this announcement.

A Visionary Breakthrough: VISTA Eye Specialist and EssilorLuxottica Join Forces to Combat Childhood Myopia in Malaysia

PETALING JAYA, Malaysia, April 25, 2025 /PRNewswire/ — In a landmark move to safeguard the vision of Malaysia’s future generation, VISTA Eye Specialist (‘VISTA’), the nation’s trusted eye care brand, announced a strategic collaboration Memorandum of Understanding (MoU) with EssilorLuxottica, the global leader in Medtech for vision care.

VISTA Eye Specialist signs MoU with EssilorLuxottica Malaysia to strengthen efforts against childhood myopia.
VISTA Eye Specialist signs MoU with EssilorLuxottica Malaysia to strengthen efforts against childhood myopia.

This partnership heralds a nationwide initiative to tackle the silent epidemic of childhood myopia, combining clinical excellence, global innovation, and a deep commitment to community health.

Myopia: More Than Just Blurry Vision

Myopia (short-sightedness) is emerging as a significant public health concern. Left unmanaged, it doesn’t just require glasses with higher prescriptions. It opens the door to a lifetime of serious vision-threatening complications[1&2], therefore myopia management from an early age is critical[3].

“The world sees myopia as a childhood inconvenience. But unchecked, it becomes a lifetime disability,” said Lim Boon Siong, Director of VISTA Eye Specialist. “Our children deserve better—and we’re stepping up.”

The Hidden Dangers of High Myopia[1]:

  • Retinal Detachment – Eye elongation can stretch and thin the retina, leading to tears or detachment that may cause sudden, irreversible blindness.
  • Myopic Macular Degeneration (MMD) – A leading cause of permanent central vision loss, especially in adults who were highly myopic as children.
  • Glaucoma – Myopic eyes are more vulnerable to this “silent thief of sight”, which causes progressive, irreversible damage to the optic nerve.
  • Early Cataracts – High myopia increases the risk of early-onset cataracts, which often require surgery earlier in life.

By 2050, it’s projected that 1 in 2 people globally will be myopic[2]. In parts of Asia, including Malaysia, up to 80–90% of schoolchildren already show signs of myopia. The time to act is now.

VISTA & EssilorLuxottica: A United Vision

Through this MoU, VISTA and EssilorLuxottica commit to an ambitious, multi-pronged strategy:

EssilorLuxottica Malaysia will:

  • Lead nationwide myopia management educational and awareness campaigns—including webinars, digital content, and parent workshops—to empower families with crucial knowledge about myopia prevention myopia management and control.

VISTA Eye Specialist will:

  • Deliver comprehensive myopia screenings through its extensive network of centers
  • Establish a referral program to connect diagnosed children with tailored myopia management solutions
  • Launch a CSR campaign starting with a free eye clinic for 200 underprivileged children, supported by volunteers from the OneSight EssilorLuxottica Foundation
  • Expand outreach to include adults and seniors, fostering lifelong eye health for all

“This is about safeguarding vision and reduce the risk of severe eye conditions linked to high myopia,” said Denis Chng, Country Manager of EssilorLuxottica Malaysia. “We have to act now—healthy eyes today ensure clear sight for a lifetime!”

Looking Ahead: Hope in Sight

This collaboration marks just the beginning. Both organizations aim to scale this initiative across Malaysia—from cities to underserved rural communities. Their shared goal is to drastically reduce the incidence and impact of myopia by prioritizing early intervention, education on myopia management, and access to vision care.

About VISTA Eye Specialist

Established in 1999, VISTA Eye Specialist is Malaysia’s most trusted name in eye care. VISTA was recently honored with Newsweek’s Asia’s Top Private Hospital Awards 2025, recognizing its dedication to clinical excellence, innovation, and patient satisfaction. With a strong presence across the country and more than 460,000 satisfied patients, VISTA is renowned for its excellence in LASIK, cataract, and myopia control services. VISTA’s commitment goes beyond treatment—it is about transforming lives through vision.

About EssilorLuxottica

EssilorLuxottica is a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. With over 200,000 employees across 150 countries, 650 operations facilities and 18,000 stores, in 2023 the Company generated consolidated revenue of Euro 25.4 billion. Its mission is to help people around the world to see more and be more by addressing their evolving vision needs and personal style aspirations. EssilorLuxottica is home to the most advanced lens technologies including Varilux, Stellest and Transitions, the most iconic eyewear brands including Ray-Ban and Oakley, the most desired luxury licensed brands and world-class retailers including LensCrafters and Sunglass Hut. The Company’s OneSight EssilorLuxottica Foundation has given access to sustainable vision care to more than 760 million people in underserved communities. 

Reference

  1. Haarman AEG, Enthoven CA, Tideman JWL, Tedja MS, Verhoeven VJM, Klaver CCW. The Complications of         Myopia: A Review and Meta-Analysis. Invest Ophthalmol Vis          Sci. 2020;61(4):49. doi:10.1167/iovs.61.4.49
  2. Holden BA,      Fricke TR, Wilson DA, et al. Global Prevalence of Myopia and High           Myopia and Temporal Trends from 2000 through 2050. Ophthalmology.             2016;123(5):1036-1042. doi:10.1016/j.ophtha.2016.01.006
  3. K. Zadnik, G.L. Mitchell, L.A. Jones, D.O. Mutti; Factors Associated with    Rapid Myopia Progression in School–aged Children . Invest.       Ophthalmol. Vis. Sci. 2004;45(13):2306.

 

Global Media Witnesses Chery Super Hybrid (CSH)’s Breakthrough as ‘Endless Horizon Worry-Free Voyage’ Endurance Challenge Completes First Stage

SHANGHAI, April 25, 2025 /PRNewswire/ — On April 23, coinciding with the opening day of 2025 Shanghai Auto Show, the first stage of Chery Super Hybrid (CSH) “Endless Horizon Worry-Free Voyage” endurance challenge successfully concluded. This four-day challenge featured Chery’s hybrid duo – TIGGO9 CSH and ARRIZO8 CSH – leading an international media convoy from Malaysia, Poland, the Czech Republic and other countries. The journey started from Sanxia and traversed Wuhan and Wuzhen, covering over 1,400 kilometers before concluding in Shanghai. This rigorous test strengthened global users’ recognition and approval of Chery’s hybrid vehicles.

International Media Guests Completed CSH "Endless Horizon Worry-Free Voyage" Endurance Challenge
International Media Guests Completed CSH “Endless Horizon Worry-Free Voyage” Endurance Challenge

Spanning 1,400+ kilometers, the challenge covered every driving scenario—urban traffic jams, mountain switchbacks and high-speed cruising. CSH’s advantages translate into real-world benefits, thanks to breakthroughs in fundamental architecture. The fifth-generation 1.5TGDI dedicated hybrid engine sets a new benchmark with 44.5% thermal efficiency. Paired with the stepless electric hybrid DHT system featuring 98.5% transmission efficiency, it balances power and efficiency perfectly. These innovations drive comprehensive performance leadership in both TIGGO9 CSH and ARRIZO8 CSH.

The “Endless Horizon Worry-Free Voyage” endurance challenge focused on vehicle range, with both models exceeding 1,400 kilometers — eliminating range anxiety. ARRIZO8 CSH recorded a fuel consumption of just 4.2L/100km in battery-depleted mode, while TIGGO9 CSH, equipped with a dedicated hybrid battery, achieved a fast charge (30%-80%) in only 20 minutes. Additionally, it features a 6.6kW V2L function, perfect for powering outdoor equipment during camping trips. Both models maintained 120 km/h throughout a 600-kilometer highspeed test, showcasing robust power performance. With nearly 20 ADAS features, APA, and a quiet cabin noise level of 60 dBA at 120 km/h, they deliver an intelligent, safe, and comfortable driving experience.

The event not only showcased the brand’s technological capabilities but also embodied its philosophy of “technology equality.” After the China stage, the challenge will commence its Malaysian part next. Moving forward, the event will include over 40 real-world tests across more than 20 countries and regions with the participation of more models from the CSH lineup, demonstrating the system’s “all-scenario, worry-free” adaptability in diverse environments.

ZERO BREEZE Partners with NASCAR Driver Patrick Emerling to Bring Cooling Innovation to the Track

LINCOLN, Ala., April 25, 2025 /PRNewswire/ — ZERO BREEZE, a leader in portable air conditioning technology, is thrilled to announce its official partnership with Patrick Emerling, the accomplished NASCAR Xfinity Series driver. Both ZERO BREEZE and Emerling share a relentless pursuit of excellence in their respective fields—Emerling’s commitment to speed and precision on the racetrack and ZERO BREEZE’s dedication to pioneering innovative outdoor cooling solutions. Together, they represent a dynamic collaboration driven by a shared passion for high performance.

ZERO BREEZE Collaborates with NASCAR Driver Patrick Emerling
ZERO BREEZE Collaborates with NASCAR Driver Patrick Emerling

Unmatched Cooling Performance on and off the Track

Throughout this partnership, Emerling will utilize the Mark 3 Portable Air Conditioner (‘Mark 3’) in his racing operations, offering a firsthand look at its advanced cooling capabilities in the demanding world of motorsports. Whether on the racetrack, in the pit crew’s workspace, or in Emerling’s motorhome, the Mark 3 ensures drivers, teams, and crew members stay comfortable and focused during grueling race days. Its rapid cooling performance helps maintain peak efficiency and focus on race day, keeping everyone cool under pressure.

Patrick Emerling: A Champion of Speed and Precision

Patrick Emerling has earned numerous awards throughout his racing career, including multiple victories in the NASCAR Whelen Modified Tour and a recent win at the World Series of Asphalt Stock Car Racing at New Smyrna Speedway in 2025. Known for his consistency, strategic approach, and unwavering drive, Emerling’s passion for precision mirrors the ethos of ZERO BREEZE.

Emerling’s love for machinery and cutting-edge equipment goes beyond racing, making him the perfect partner for ZERO BREEZE—a brand that thrives on innovation. Just as Emerling pushes the limits of speed and concentration on the track, the Mark 3 pushes the boundaries of cooling performance, offering quick and powerful temperature reductions. With the ability to drop temperatures by 20°F within just 5 minutes, the Mark 3 is engineered to handle the scorching heat of tracks. On April 26 at the NASCAR Xfinity Series at Talladega Superspeedway, the Mark 3 will play a crucial role in helping Emerling and his team stay cool and focused, ensuring their peak performance.

ZERO BREEZE: The Future of Trackside Portable Cooling

While this marks ZERO BREEZE’s first official partnership with a NASCAR driver, the brand has already made its mark in motorsports. Previously, the Mark 2 Portable Air Conditioner was seen at summer race weekends, providing effective cooling for drivers and teams. Whether cooling a driver in the cockpit before the race or offering a refreshing break to the team after a long race, the Mark 2’s portability and battery-powered design made it a go-to solution for racing teams in need of quick, efficient cooling.

This year, the Mark 3 has been recognized as “Most Portable AC” by T3, a leading technology media outlet, thanks to its enhanced performance, portability, and ease of use. With a 5280 BTU cooling capacity—more than double that of its predecessor—the Mark 3 is set to elevate cooling efficiency to new heights. Emerling will now experience the Mark 3’s superior capabilities, ensuring that he remains comfortable and focused during race days.

Off the track, Emerling will also use the Mark 3 in his motorhome, ensuring that he stays cool and sharp throughout the weekend. His team will benefit from the Mark 3 in the pit and garage, ensuring a comfortable and productive environment where focus is key.

A Partnership That Bridges Speed and Comfort

Max Ma, the founder of ZERO BREEZE, states, “We’re incredibly excited to welcome Patrick Emerling to the ZERO BREEZE family. This partnership is not only a testament to our shared commitment to excellence but also an exciting opportunity to bring the power of cooling technology to the racetrack. Imagine the driver using the Mark 3 on the track, while fans in the camping areas are also using the Mark 3 in their tents, RVs, or vans for cooling, sharing in the speed, passion, and comfort.”

With an audience of 40,000-120,000 campers at every NASCAR race weekend, ZERO BREEZE is perfectly positioned to meet the needs of race fans looking for comfort and convenience while enjoying the race day excitement. Talladega’s legendary race weekend, attracting thousands of camping fans, will serve as the ideal debut for this collaboration, combining the thrill of racing with the cooling power of the Mark 3.

Join the Cool Revolution at the Track

With summer racing season heating up, there’s no better time to discover the cooling power of the ZERO BREEZE Mark 3. Whether you’re trackside, on the road in your motorhome, or venturing into the wild, the Mark 3 delivers portable comfort wherever your journey takes you.

As part of its ongoing partnership with NASCAR driver Patrick Emerling, ZERO BREEZE is offering an exclusive $50 discount for new subscribers. Don’t miss this limited-time offer—available through April 30. Learn more and claim your discount at ZERO BREEZE online store.

About ZERO BREEZE

ZERO BREEZE is a leading provider of portable air conditioning solutions designed to handle extreme outdoor conditions. The Mark 3 is the most advanced portable air conditioner, offering high-efficiency cooling for outdoor enthusiasts, racers, campers, and professionals in demanding environments. Known for its portability, performance, and battery-powered feature, ZERO BREEZE continues to revolutionize the way people stay cool under pressure.

Theo Raises $20M to Democratize Access to Institutional-Grade Trading Infrastructure

Founded by ex-Optiver and IMC quants, the platform is backed by angels from Citadel, Jane Street, and JPMorgan

NEW YORK, April 25, 2025 /PRNewswire/ — Theo, a novel network connecting onchain capital to global markets via institutional-grade trading infrastructure, today announced it has raised $20 million in funding. The round was jointly led by Hack VC and Anthos Capital, with participation from numerous other venture capital firms, including Manifold Trading, Mirana Ventures, Metalayer Ventures, Flowdesk, SCB, MEXC, Amber Group, and Selini Capital, as well as angels from a range of leading TradFi trading firms including Citadel, Jane Street, HRT, Optiver, IMC, 5 Rings, and JPMorgan. 

Founded by former quant traders; Abhi Pingle, Arijit Pingle, and TK Kwon who honed their expertise at elite trading firms Optiver and IMC Trading, Theo was born from a recognition: while onchain capital is growing exponentially, access to traditional and institutional-grade strategies remain out of reach for everyday users. Theo aims to bridge this gap – delivering the sophistication of Wall Street to the retail investor.

Theo’s platform provides access to institutional-grade trading infrastructure that supports a wide range of strategies traditionally reserved for hedge funds and proprietary trading firms. At its core, Theo operates a custom low-latency validator set that ensures custodial guarantees for users, while enforcing rule-based access for institutional counterparties like market makers and trading firms.

These validators facilitate real-time execution across centralized exchanges (CEXes) and decentralized protocols (DeFi), while enforcing margin requirements and maintaining system-wide overcollateralization. Retail users can access these strategies via a simple deposit into strategy-specific vaults—without the complexity of multiple exchange accounts or algorithmic trading knowledge.

“Today’s crypto markets are fragmented and inefficient, preventing institutions and everyday users alike from accessing the full promise of global, permissionless finance,” says Abhi Pingle, co-founder of Theo. “Theo solves this by delivering robust, scalable infrastructure that seamlessly connects large traditional players and retail participants on-chain—unlocking new levels of capital efficiency.”

Theo strategies allow anyone to passively access professional trading strategies by simply depositing assets, with the platform handling execution, risk, and dynamic capital allocation across approaches like high-frequency arbitrage, cross-chain funding rate optimization, and advanced hedging.

As market conditions shift, Theo’s infrastructure dynamically reallocates capital to maintain performance, where single-strategy platforms often see returns diminish. This flexibility ensures greater stability and performance for retail participants.

For trading firms, Theo enables superior capital efficiency. By leveraging user capital through vault participation, firms can cross-margin strategy positions against their proprietary trades—unlocking alpha while users share in the upside. This creates a mutually beneficial ecosystem: institutional-grade strategies, retail accessibility, and shared value creation.

Theo’s architecture is uniquely positioned to connect traditional and crypto-native financial venues. As the industry evolves, Theo’s role as an infrastructure layer will be instrumental in bridging legacy markets and the onchain economy—democratizing access to advanced financial tools worldwide.

About Theo

Theo is an institutional-grade trading infrastructure platform founded by former quant traders from IMC Trading and Optiver. The platform enables retail users to access sophisticated high-frequency trading and market-making strategies previously available only to Wall Street firms, while providing trading firms with new opportunities to capture alpha through their market expertise with superior capital efficiency. Learn more at theo.xyz

VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Non-Infectious Anterior Uveitis

  • VVN461, a dual JAK1/TYK2 inhibitor as a non-steroidal anti-inflammatory agent, has met primary endpoints, demonstrating non-inferior efficacy compared to the standard therapy, prednisolone acetate (PA) in treating NIAU
  • Clinically meaningful reductions in inflammation compared to baseline observed as early as Day 3
  • Strong safety profile with no substantial treatment-related adverse events reported

WENZHOU, China, April 25, 2025 /PRNewswire/ — VivaVision Biotech (VivaVision), a clinical-stage, privately held biotechnology company focused on developing innovative treatments for ocular diseases, today announced positive topline results from its phase 2 clinical trial of VVN461, a potent dual JAK1/TYK2 inhibitor for the treatment of Non-Infectious Anterior Uveitis (NIAU) in China.

This is a multicenter, double-masked, randomized, active-controlled, parallel-comparison study conducted at 10 clinical sites in China enrolling 86 subjects with NIAU. Subjects were randomized into three groups (VVN461-1.0%, VVN461-0.5%, and prednisolone acetate-1.0%) and received treatments for 28 days. Prednisolone acetate is the first-line corticosteroid therapy for NIAU.

Both 0.5% and 1% of VVN461 ophthalmic solutions showed non-inferior efficacy compared to active control PA for its primary endpoint: subjects treated with VVN461 had 2 step decrease in ACC grade vs. subjects treated with prednisolone acetate (p <0.001). Note: ACC (anterior chamber cells) were evaluated using SUN grading scale.

Both VVN461 dose groups demonstrated statistically significant and clinically meaningful improvements from baseline across most primary and secondary endpoints. The efficacy of VVN461 groups were comparable to prednisolone acetate group. No substantial treatment-related adverse events were reported, confirming VVN461’s excellent safety profile.

Full data will be reported in future publications in conferences and journals.

“I am very pleased to see that VVN461 showed non-inferior efficacy to prednisolone acetate in the phase 2 clinical trial for NIAU in China. This is a very significant and potentially disruptive progress in treating uveitis.” said Professor. Liu Yang, Director of Ophthalmology at Peking University First Hospital, “We hope that this safe, highly efficacious and accessible non-steroidal medicine, VVN461 would be available to benefit patients in near future.”

Uveitis is the inflammation of uvea which consists of the iris, ciliary body, and choroid. Uveitis affects approximately 3 million patients in China with ~60% classified as NIAU. Uveitis may recur and be chronic, and it is a leading cause of vision loss accounting 10–20% of cases of acquired legal blindness. Treatment of NIAU typically involves the use of topical steroids, which are associated with adverse effects such as increased intraocular pressure, delayed wound healing, and ocular infections. Repeated or chronic use of topical steroids may lead to severe side effects, such as ocular hypertension and cataract. Therefore, the effective control of uveitis inflammation with minimization of side effects is critically needed. VVN461 offers a promising alternative, leveraging its targeted, non-steroidal mechanism to minimize these risks while maintaining anti-inflammatory efficacy.

 VivaVision has scheduled a discussion with Chinese CDE and is planning to request a type C meeting with FDA about phase 3 clinical trials.

About VivaVision Biotech

Founded in 2016, VivaVision Biotech is a clinical-stage pharmaceutical company dedicated to advancing best-in-class therapies with additional investigational drug candidates for ocular diseases. The company’s leading pipeline assets include:

  • VVN461: a non-steroidal dual JAK1/TYK2 immunomodulator for post-operative inflammation after cataract surgery and non-infectious anterior uveitis.
  • VVN001: an investigational treatment for dry eye syndrome.
  • VVN1901: a therapy for targeting neurotrophic keratitis
  • VVN481:  a non-steroidal dual JAK1/TYK2 inhibitor for suprachoroidal delivery to treat posterior/pan-uveitis and posterior inflammatory diseases
  • VVN432: a non-steroidal JAK inhibitor nasal spray for chronic rhinosinusitis (CRS)

In addition to its pipeline, VivaVision is actively engaged in the discovery and development of additional therapies for anterior and posterior segment eye diseases to address unmet patient needs. For more information, please visit www.vivavisionbio.com.

China Media Contact
Ruby SUN
Phone: +86 181-1619-2461
Email: yanyan.sun@vivavisionbio.com

Medit and Graphy Announce Strategic Partnership to Advance Digital Orthodontics

SEOUL, South Korea, April 25, 2025 /PRNewswire/ — Medit, a global leader in digital dentistry solutions, and Graphy, a leading innovator in 3D printing dental materials, have officially announced a strategic partnership to accelerate advancements in the digital orthodontics market.

Medit and Graphy Announce Strategic Partnership to Advance Digital Orthodontics
Medit and Graphy Announce Strategic Partnership to Advance Digital Orthodontics

The partnership brings together Medit’s expertise in intraoral scanning and open digital workflows with Graphy’s groundbreaking material technology, including the world’s first directly 3D-printed clear aligners. The two companies will co-develop next-generation orthodontic solutions that deliver greater speed, accuracy, and efficiency across every stage — from diagnosis to appliance fabrication.

By integrating their technologies, Medit and Graphy aim to enhance user experience for both clinicians and patients, enabling a more seamless and predictable digital orthodontic journey. Further areas of cooperation will be defined as the partnership evolves.

About Medit
Medit Corp. is a global leader in digital dentistry solutions, known for its cutting-edge intraoral scanners and open-platform workflow systems. Headquartered in Seoul, South Korea, Medit develops and supplies the i-Series scanners (including the i700 and i900), which are widely recognized for their speed, accuracy, and ease of use. These scanners are adopted by thousands of clinics and labs across the globe.

Through its cloud-based Medit Link platform, Medit enables seamless integration of scanning, treatment planning, and case management, empowering dental professionals with enhanced flexibility and connectivity in their digital workflows.

Medit’s commitment to open architecture and intuitive software tools has positioned the company at the forefront of the digital dentistry revolution, driving accessibility and innovation across the global market.

About Graphy
Graphy Co., Ltd. is a Korea-based materials science company specializing in high-performance, biocompatible photopolymer resins specifically designed for 3D printing in digital dentistry. With its proprietary oligomer synthesis technology, Graphy independently formulates and manufactures advanced resins that offer superior mechanical properties and stability compared to conventional materials.

Under its flagship brand Tera Harz, Graphy provides material solutions for a wide range of dental applications, including shape memory clear aligners, crowns, bridges, and surgical guides.

Notably, Graphy is the first company in the world to commercialize resin for directly 3D-printed shape memory clear aligners, setting a new standard in functional dental 3D printing and leading the evolution of in-office orthodontic solutions.

 

Atomicwork launches its Universal Agent, bringing Multimodal AI to every employee’s flow of work

This first-of-its-kind Universal Agent eliminates manual work with Voice and Vision AI to make end-users and IT teams 10x more productive

SAN FRANCISCO, April 25, 2025 /PRNewswire/ — Atomicwork today launched its Universal Agent, a new multimodal AI solution that delivers proactive and context-aware support across enterprise applications and devices. The voice-enabled video support drastically reduces ticket volumes by 60% for enterprise service teams like IT, HR, BizOps, and Finance while improving end-user satisfaction by 25%.

Atomicwork seamlessly integrates into employees’ flow of work across business applications on their browsers and devices including collaboration apps like Microsoft Teams, Slack and Email. Atomicwork keeps employees moving – no tickets, no detours, just instant help right in their flow of work – so IT teams can finally ditch the drag of legacy ITSM and ESM tools.

“Legacy ITSM was built for managing tickets. Atomicwork is built to eliminate them,” said Vijay Rayapati, co-founder and CEO of Atomicwork. “With Universal AI at the core, we’re moving from systems of record to systems that act. Context-aware, conversational, and cross-platform in the flow of work – this is how enterprise service delivery should work in an AI-first world.”

Enterprise IT can now give every employee ambient, always-on support

Unlike traditional ITSM tools that expect end-users to recall and describe their issues via email or create tickets on portals, the Universal Agent can proactively engage with end-users wherever they are and in whatever mode they prefer. This includes:

  • Voice AI – Natural, intuitive conversational intelligence to provide step-by-step guidance and instant resolutions.
  • Vision AI – Real-time video and screenshare assistance to diagnose complex IT issues while minimizing back-and-forth and accelerating support.
  • Work AI – Browser agents that execute end to end business processes, improving enterprise productivity and enabling employee self-service at scale.

“Atomicwork is fundamentally reshaping our digital workplace strategy. It enables us to deliver intelligent support at scale – without forcing employees to navigate multiple systems or complex interfaces. This shift from reactive ticketing to proactive support through agentic AI is not just enhancing user experience, it’s driving operational efficiency across our business,” said Karthik Chakkarapani, CIO of Zuora, an Atomicwork customer.

Early adopters have seen nearly 60% drop in ticket volume for complex issues, resolution times reduced by over 80%, and employee satisfaction scores improve by more than 25%.

“We built the Universal Agent to bring the ease and experience of Alexa and Siri to the workplace, with the power and controls that enterprises expect,” said Aparna Chugh, Head of Product at Atomicwork. “Whether it’s fixing your Mac issues, creating a purchase order, or researching a sales prospect – it works across your business apps, understands intent, and gets work done. It’s the AI teammate every employee has been waiting for from their IT team.”

Availability 

The Universal Agent will be available for all Atomicwork’s customers and partners starting today. To book a demo for your team, please sign up at atomicwork.com.

About Atomicwork 

Atomicwork is a modern service management platform, built for the AI era. With agentic AI, it automates routine IT tasks, unifies internal workflows, and delivers instant, contextual ITSM and ESM across Slack, Teams, and the browser – empowering IT teams to focus on strategic initiatives that drive business growth.

Trusted by seasoned CIOs and enterprise IT teams, Atomicwork transforms IT service management while delivering exceptional employee experiences to accelerate business productivity.  Headquartered in San Francisco, Atomicwork serves global enterprises with offices in India and Singapore.